Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational database

BACKGROUND: Pneumocystis jiroveci pneumonia (PCP) prophylaxis is recommended for patients with CD4 counts of less than 200 cells/mm(3). This study examines the proportion of patients in the TREAT Asia HIV Observational Database (TAHOD) receiving PCP prophylaxis, and its effect on PCP and mortality....

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Poh-Lian, Zhou, Jialun, Ditangco, Rossana A, Law, Matthew G, Sirisanthana, Thira, Kumarasamy, Nagalingeswaran, Chen, Yi-Ming A, Phanuphak, Praphan, Lee, Christopher KC, Saphonn, Vonthanak, Oka, Shinichi, Zhang, Fujie, Choi, Jun Y, Pujari, Sanjay, Kamarulzaman, Adeeba, Li, Patrick CK, Merati, Tuti P, Yunihastuti, Evy, Messerschmidt, Liesl, Sungkanuparph, Somnuek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354658/
https://www.ncbi.nlm.nih.gov/pubmed/22281054
http://dx.doi.org/10.1186/1758-2652-15-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354658/
https://www.ncbi.nlm.nih.gov/pubmed/22281054
http://dx.doi.org/10.1186/1758-2652-15-1

Ejemplares similares